Exchange: NYSEArca·Updated 07:30 PM EDT
News
all
press releases
BNTX Shares Rise On Goldman Sachs Upgrade, Optimism For Cancer Portfolio
Goldman raised the price target on BioNTech SE to $142, up from $115.
Stocktwits

Advertisement|Remove ads.